Medpace Holdings Price to Sales Ratio 2014-2025 | MEDP
Historical PS ratio values for Medpace Holdings (MEDP) over the last 10 years. The current P/S ratio for Medpace Holdings as of July 18, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Medpace Holdings P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-07-18 | 311.87 | 4.60 | |
| 2025-03-31 | 304.69 | $67.75 | 4.50 |
| 2024-12-31 | 332.23 | $65.81 | 5.05 |
| 2024-09-30 | 333.80 | $64.70 | 5.16 |
| 2024-06-30 | 411.85 | $63.59 | 6.48 |
| 2024-03-31 | 404.15 | $61.72 | 6.55 |
| 2023-12-31 | 306.53 | $59.25 | 5.17 |
| 2023-09-30 | 242.13 | $55.31 | 4.38 |
| 2023-06-30 | 240.17 | $51.70 | 4.65 |
| 2023-03-31 | 188.05 | $47.52 | 3.96 |
| 2022-12-31 | 212.41 | $43.13 | 4.93 |
| 2022-09-30 | 157.17 | $39.61 | 3.97 |
| 2022-06-30 | 149.67 | $35.59 | 4.21 |
| 2022-03-31 | 163.59 | $32.54 | 5.03 |
| 2021-12-31 | 217.64 | $30.33 | 7.18 |
| 2021-09-30 | 189.28 | $29.03 | 6.52 |
| 2021-06-30 | 176.63 | $27.25 | 6.48 |
| 2021-03-31 | 164.05 | $25.37 | 6.47 |
| 2020-12-31 | 139.20 | $24.55 | 5.67 |
| 2020-09-30 | 111.75 | $23.78 | 4.70 |
| 2020-06-30 | 93.02 | $23.40 | 3.98 |
| 2020-03-31 | 73.38 | $23.63 | 3.11 |
| 2019-12-31 | 84.06 | $22.94 | 3.66 |
| 2019-09-30 | 84.04 | $22.03 | 3.81 |
| 2019-06-30 | 65.42 | $21.14 | 3.09 |
| 2019-03-31 | 58.97 | $20.06 | 2.94 |
| 2018-12-31 | 52.93 | $19.15 | 2.76 |
| 2018-09-30 | 59.91 | $16.77 | 3.57 |
| 2018-06-30 | 43.00 | $14.76 | 2.91 |
| 2018-03-31 | 34.91 | $12.72 | 2.75 |
| 2017-12-31 | 36.26 | $10.81 | 3.35 |
| 2017-09-30 | 31.90 | $10.96 | 2.91 |
| 2017-06-30 | 29.00 | $11.01 | 2.63 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $8.964B | $2.109B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $136.013B | 25.51 |
| CVS Health (CVS) | United States | $78.381B | 9.74 |
| Elevance Health (ELV) | United States | $62.604B | 8.39 |
| Cencora (COR) | United States | $56.765B | 19.75 |
| DiDi Global (DIDIY) | China | $26.874B | 28.55 |
| Labcorp Holdings (LH) | United States | $20.399B | 16.55 |
| Natera (NTRA) | United States | $18.966B | 0.00 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.991B | 0.00 |
| CochLear (CHEOY) | Australia | $13.143B | 0.00 |
| Solventum (SOLV) | United States | $12.678B | 13.42 |
| ICON (ICLR) | Ireland | $11.592B | 10.78 |
| Revvity (RVTY) | United States | $10.993B | 18.92 |
| Viatris (VTRS) | United States | $10.422B | 3.58 |
| Avantor (AVTR) | United States | $9.056B | 13.16 |
| Sonic Healthcare (SKHHY) | Australia | $8.852B | 0.00 |
| HealthEquity (HQY) | United States | $8.449B | 37.01 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.680B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.587B | 14.87 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.918B | 28.96 |
| BrightSpring Health Services (BTSG) | United States | $3.506B | 32.17 |
| Sotera Health (SHC) | United States | $3.139B | 17.84 |
| Surgery Partners (SGRY) | United States | $2.861B | 37.20 |
| Concentras Parent (CON) | United States | $2.507B | 14.49 |
| Organon (OGN) | United States | $2.459B | 2.61 |
| Alignment Healthcare (ALHC) | United States | $2.455B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.222B | 85.57 |
| Progyny (PGNY) | United States | $1.886B | 41.51 |
| PACS (PACS) | United States | $1.823B | 0.00 |
| Premier (PINC) | United States | $1.725B | 13.09 |
| GoodRx Holdings (GDRX) | United States | $1.672B | 33.43 |
| Ardent Health (ARDT) | United States | $1.589B | 6.77 |
| Teladoc Health (TDOC) | United States | $1.412B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $1.277B | 438.00 |
| Establishment Labs Holdings (ESTA) | $1.202B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.080B | 8.22 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.878B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.759B | 7.10 |
| CareDx (CDNA) | United States | $0.663B | 10.36 |
| Nutex Health (NUTX) | United States | $0.632B | 9.57 |
| So-Young (SY) | China | $0.595B | 0.00 |
| SBC Medicals (SBC) | United States | $0.585B | 0.00 |
| Embecta (EMBC) | United States | $0.572B | 3.85 |
| InnovAge Holding (INNV) | United States | $0.531B | 0.00 |
| LifeMD (LFMD) | United States | $0.479B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.470B | 10.58 |
| Sonida Senior Living (SNDA) | United States | $0.466B | 0.00 |
| Omada Health (OMDA) | $0.453B | 0.00 | |
| COMPASS Pathways (CMPS) | United Kingdom | $0.402B | 0.00 |
| Enhabit (EHAB) | United States | $0.342B | 28.12 |
| Oncology Institute (TOI) | United States | $0.312B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.297B | 0.00 |
| Beauty Health (SKIN) | United States | $0.200B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.146B | 0.00 |
| DocGo (DCGO) | United States | $0.146B | 23.83 |
| Sera Prognostics (SERA) | United States | $0.110B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.079B | 0.00 |
| KindlyMD (NAKA) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.047B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.044B | 0.00 |
| ModivCare (MODV) | United States | $0.043B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.043B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |